Sign in

CIK 0001783328

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

TScan Therapeutics, Inc.

Sign in to watch
Ticker
TCRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
825282075
Phone
+1 857-399-9500
Business address
830 WINTER STREET, WALTHAM, MA, 02451
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-02 SOUTHWELL DAVID P Chief Executive Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2022-07-25 SOUTHWELL DAVID P Chief Executive Officer Grant or award · Stock Option (Right to Buy) +100,000 100,000
2022-05-18 SOUTHWELL DAVID P Chief Executive Officer Purchase +15,000 $3.62 $54K 161,569
2022-05-18 SOUTHWELL DAVID P Chief Executive Officer Purchase +10,000 $3.55 $35K 171,569
2022-01-18 SOUTHWELL DAVID P Chief Executive Officer Grant or award · Stock Option (Right to Buy) +275,000 275,000
2021-12-23 SOUTHWELL DAVID P Chief Executive Officer Option exercise +48,670 $1.97 $96K 146,569
2021-12-23 SOUTHWELL DAVID P Chief Executive Officer Option exercise · Stock Option (Right to Buy) −48,670 21,161
2021-09-08 SOUTHWELL DAVID P Chief Executive Officer Purchase +11,000 $8.73 $96K 97,899

Page 1 of 1 · 8 trades